Matinas BioPharma Holdings, Inc.

Home » Matinas BioPharma Holdings, Inc.

Secondary

Matinas BioPharma Holdings, Inc.

We are a clinical-stage biopharmaceutical company currently focused on enabling the delivery of life-changing medicines using our unique and proprietary, lipid nano-crystal (LNC) delivery technology platform

Symbol

MTNB

Last Closing Price
$0.57

Shares
30,000,000

Anticipated Date
TBD

Underwriters
ThinkEquity A Division of Fordham Financial Management, Inc.

To view the prospectus for Matinas BioPharma Holdings, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253